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Materials and methods
Reagents. The IAP antagonist BV6 was purchased from Selleck Chemical (Houston, TX). Lipopolysaccharide (LPS) from E.coli was purchased from InvivoGen (tlrl-3pelps; San Diego, CA). Neutralizing antibodies against human IL-6 (MAB2061R), human IL-8/CXCR2
(MAB331), and human CCL2/MCP1 (MAB279) were purchased from R&D Systems (Minneapolis, MN). Cenicriviroc (CVC) was a generous gift from Allergan (South San Francisco, CA). All other reagents were from Sigma Aldrich (St. Louis, MO), unless otherwise specified.
Cell lines. The SV40-transformed, non-malignant human cholangiocyte cell line H69
(obtained from Dr. G.Jefferson, Tufts University, Boston, MA), and low-passage (passage 16), spontaneously immortalized normal human cholangiocytes (NHC, obtained from Dr. Juan Medina, University Hospital, Pamplona, Spain) were grown as previously described.
1-3 PSC patient-derived cholangiocytes (passage 4), isolated from patients with stage 4 PSC without cholangiocarcinoma, were obtained, cultured and characterized as previously described. The cells expressed cholangiocyte (cytokeratin 7 and 19) and epithelial cell adhesion markers (EpCAM, ICAM) and still retained phenotypic characteristics of disease as assessed by beta galactosidase staining for senescence and ELISA assessment of increased secretion of SASP markers. 4 The human monocytic cell line THP-1 was obtained from ATCC (Manassas, VA; TIB-202), and cultured as previously described. 5 All cell lines were tested for absence of mycoplasma For immunohistochemistry, human and mouse liver tissues were processed as previously described 6 and incubated overnight with primary antibodies against CD68 (1:200), or PanCK
(1:1000)(Supplementary CTAT Table) . Bound antibodies were detected with either biotin conjugated (Vector Laboratories, Burlingame, CA) or HRP conjugated secondary antibodies (Dako, Carpinteria, CA) using diaminobenzidine tetrahydrochoride as chromogen. Tissue slices were counterstained with hematoxylin. Hematoxylin/eosin stain was performed by standard methods. Liver fibrosis was examined using Picrosirius red staining as previously described 7 .
Images were obtained using a Nikon Eclipse TE300 microscope (Nikon, Tokyo, Japan) equipped with Nikon Digital Sight DS-Ri1. Parenchymal and peribiliary macrophages (CD68 + ) quantification was performed using the NIS Elements AR 4.60 imaging software (Nikon). The peribiliary area was defined as 50-60 µm from the basement membrane and manually determined using the image's scale bar.
For immunofluorescence, human and mouse formalin-fixed, paraffin-embedded liver tissue sections were deparaffinized, rehydrated, and exposed to heat-mediated antigen retrieval in Table) at the same concentrations as the respective primary antibodies and are provided in Suppl. 
Next generation sequencing (NGS). Gene expression profile in normal cholangiocyte
cell lines and PSC patient-derived cholangiocytes was analyzed by next generation sequencing as previously described 4 .
Enzyme-linked immunosorbant assay (ELISA).
Conditioned media were obtained as described above and stored at -80˚C until used. Human IL-6, IL-8, CCL2/MCP-1 and CCL20
(D5060, D8000C, DCP00, DM3A00; R&D Systems), CXCL2 (Ab184862, Abcam), and CXCL3
(LS-F11251-1, Lifespan Biosciences, Seattle, WA) in the supernatants were measured using ELISA kits following the manufacturer's instructions. Each assay was performed in duplicate on samples obtained from three separate experiments in triplicate. Conditioned media were obtained as described above.
Macrophage migration assays. H69, NHC, and PSC-derived cholangiocytes were plated in equal number in 6-well plates and cultured for 24 hr in complete medium. After this time, H69
and NHC reached approx. 80% confluence, whereas PSC/senescent cells grow at a slower pace, Selected experiments were performed employing static microfluidic co-culture devices fabricated as previously reported. 8 Briefly, dual-chamber microfluidic devices measuring 75 μm in height with microgrooves (100 µm in length, 5 μm in height, 10 µm in width) separating the parallel chambers were used. The microfluidic platforms were first coated with a collagen I solution (0.2 mg/ml) for 4 hours at 37°C in a cell incubator. NHC or PSC-derived cholangiocytes were seeded at a density of 2 x 10 6 cells/ml in one chamber of the device and allowed to grow in culture, whereas the second chamber was filled with culture media alone. After 48 hours, the Macrophage activation assay. THP-1 cells were resuspended in serum-free DMEM and plated in equal number in 6-well plates (approx. 5 x 10 5 cells/well). After 2 hr., when the most of the cells have adhered to the bottom of the plate, the medium was replaced with conditioned medium (1 ml) obtained from H69 cells with/without BV6 treatment, NHC, PSC-derived cholangiocytes (from two patients) and LPS-treated NHC as described above. In a subset of experiments, neutralizing antibodies against IL-6 (0.5 µg/ml), IL-8 or CCL2 were added to the conditioned media. Total RNA was collected after 6 hr and analyzed by RT-qPCR for markers of activation (IL6 and IL1β) using the primers listed in Supplemental CTAT table.
Hydroxyproline assay. Hydroxyproline assay as a direct measurement of collagen content was performed on frozen liver specimens (100 mg) as described before.
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Serum analysis. Serum alanine aminotransferase (ALT), total bile acids and total bilirubin were measured using a commercially available veterinary chemistry analyzer (VetScan 2, Abaxis, Union City, CA).
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Total RNA extraction was performed using RNeasy ® Plus mini kit (Qiagen, Hilden, Germay). RT was performed starting from 1 µg of total RNA as previously described. 6 qPCR was performed in a total volume of 10 µl containing 10 ng cDNA/reaction, at the following cycling conditions: 95°C for 5 min (activation); 95°C for 10 seconds, 60°C for 10 seconds, 72°C for 30 seconds (40 cycles, amplification); 95°C for 5 seconds, 65 C for 1 min, followed by dissociation curve analysis. Primers used are listed in Supplemental CTAT Table. Target gene expression was calculated using the ΔΔCt method and expression was normalized to GAPDH (human cells) or hypoxanthine-guanine phosphoribosyltransferase (HPRT; mouse tissue) expression levels.
Flow cytometry. Liver tissue obtained from experimental animals described above was enzyme dissociated as per manufacturer's protocol using the gentleMACS dissociator (Miltenyi Biotech, Somerville, MA). Whole cell isolates were subjected to red cell lysis using ACK buffer. Total cell number was counted on a cell counter (Cellometer Unstained NHC (control) or PSC cholangiocytes were seeded in one chamber of a microfluidic device. After 48 hr. the medium was replaced with fresh RPMI ± neutralizing antibodies against CCL2 or IL-8, and THP-1 cells (red) were plated in the adjacent chamber. Migration of THP-1 cells through the microgrooves separating the chambers and toward the cholangiocytes was visualized by fluorescence microscopy after 24 hr. co-culture (top: 4x; bottom: 10x). 
